Does Hormonal Luteal Support After Intra-uterine Insemination (IUI) Increase the Pregnancy Rate?
NCT ID: NCT00700492
Last Updated: 2015-06-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
82 participants
INTERVENTIONAL
2004-05-31
2008-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
HCG Versus Spontaneous LH in Intrauterine Insemination (IUI ) Cycles
NCT01414673
Luteal Support and Intrauterine Insemination (IUI) With Clomiphene Citrate
NCT01046708
Luteal Phase Progesterone in IUI and Gonadotropin Cycles
NCT01941875
Intrauterine Insemination and Luteal Fase Support
NCT01826747
Luteal Supplementation With Rec-LH After GnRH-agonist Triggering in In Vitro (IVF)
NCT00954811
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
control
No interventions assigned to this group
utrogestan
daily use of vaginal progesterone capsules
progesterone
vaginal capsules 3X200mg daily
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
progesterone
vaginal capsules 3X200mg daily
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Tubal patency demonstrated
* ovulation induction with human menopausal gonadotropin
Exclusion Criteria
18 Years
43 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Gasthuisberg
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Thomas D'Hooghe
Prof PhD MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thomad D'Hooghe, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University Hospital Gasthuisberg, Catholic University Leuven, Belgium
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Leuven University Fertility Center
Leuven, Vlaams Brabant, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ML2437-30/12/2003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.